The Drug-Resistant Tuberculosis (DR-TB) Program was launched in Khyber Pakhtunkhwa (KP) in April 2012 under a Consolidated Grant (CON/CG) covering the period from April to September 2012. This initiative was established through a Memorandum of Understanding (MoU) signed by key stakeholders, including the National TB Control Program (NTP), the Provincial TB Control Program Khyber Pakhtunkhwa (PTP-KP), Lady Reading Hospital (LRH) Peshawar, and the Association for Community Development (ACD).
Following the initial phase, the program progressed through the following funding cycles:
Single Stream of Funding-SSF
October 2012 – June 2015
Overview
| Country/Geography | Pakistan |
| Grant Name/Funding Request Name | PKS-T-NTP-SR-ACD |
| Implementation Period Start Date | 1-Oct-12 |
| Implementation Period End Date | 30-June 2015 |
| Reporting Frequency (Months) | 3 |
| Allocation Utilization Period Start Date | 1-Oct-12 |
| Allocation Utilization Period End Date | 30-June 2015 |
Goal
To reduce the burden of TB in Pakistan by 2015 in line with Global TB Plan.
Objective
To Enhance the Capacity of Health Sector to detect and manage 80% of the estimated DR-TB incident cases by year 2015 (NTP PR)
New Funding Model - NFM 2
January 2018 - June 2021
Overview
| Country/Geography | Pakistan |
| Grant Name/Funding Request Name | PKS-T-NTP-SR-ACD |
| Implementation Period Start Date | 01-January-2018 |
| Implementation Period End Date | 30-June-2021 |
| Reporting Frequency (Months) | 6 |
| Allocation Utilization Period Start Date | 01-July-2015 |
| Allocation Utilization Period End Date | 01-January-2018 |
Goal
Contribute towards decreasing the prevalence, by at least 5% per year from 2018 onwards, the prevalence of MDR-TB among TB patients who have never received any TB treatment
Objective
To enhance MDR-TB enrollment from 18% of estimated cases in 2014-15 to 33% of estimated by 2020
New Funding Model-NFM
July 2015 - December 2017
Overview
| Country/Geography | Pakistan |
| Grant Name/Funding Request Name | PKS-T-NTP-SR-ACD |
| Implementation Period Start Date | 01-July-2015 |
| Implementation Period End Date | 31-December-2017 |
| Reporting Frequency (Months) | 3 |
| Allocation Utilization Period Start Date | 01-July-2015 |
| Allocation Utilization Period End Date | December-2017 |
Goal
Contribute towards decreasing the prevalence, by at least 5% per year from 2018 onwards, the prevalence of MDR-TB among TB patients who have never received any TB treatment.
Objective
To enhance MDR-TB enrollment from 18% of estimated cases in 2013-14 to 23% of estimated by 2017
New Funding Model - NFM 3
July 2021 - December 2023
Overview
| Province/Geography | Khyber Pakhtunkhwa |
| Grant Name/Funding Request Name | PKS-T-NTP-SR-ACD |
| Implementation Period Start Date | 01/July/2021 |
| Implementation Period End Date | 31-December 2021 |
| Reporting Frequency (Months) | 6 |
| Allocation Utilization Period Start Date | 01/January/2021 |
| Allocation Utilization Period End Date | 31-December 2023 |
Goal
- To reduce the TB mortality rate by 40% by 2023 compared to 2015
- To reduce estimated TB incidence by at least 4% in 2023 compared to 2015
Objective
To Enhance the Capacity of Health Sector to detect and manage 80% of the estimated DR-TB incident cases by year 2015 (NTP PR)